388 related articles for article (PubMed ID: 16228234)
61. [Neoadjuvant treatment in surgery of esophageal cancer].
Launois B; Raoul JL; Leprise E; Meunier B
Bull Acad Natl Med; 2000; 184(8):1703-13; discussion 1714. PubMed ID: 11471389
[TBL] [Abstract][Full Text] [Related]
62. Induction therapy for clinical T4 oesophageal carcinoma; a plea for continued surgical exploration.
Van Raemdonck D; Van Cutsem E; Menten J; Ectors N; Coosemans W; De Leyn P; Lerut T
Eur J Cardiothorac Surg; 1997 May; 11(5):828-37. PubMed ID: 9196296
[TBL] [Abstract][Full Text] [Related]
63. A phase II study of perioperative concurrent chemotherapy, gefitinib, and hyperfractionated radiation followed by maintenance gefitinib in locoregionally advanced esophagus and gastroesophageal junction cancer.
Rodriguez CP; Adelstein DJ; Rice TW; Rybicki LA; Videtic GM; Saxton JP; Murthy SC; Mason DP; Ives DI
J Thorac Oncol; 2010 Feb; 5(2):229-35. PubMed ID: 20009775
[TBL] [Abstract][Full Text] [Related]
64. Node status in transmural esophageal adenocarcinoma and outcome after en bloc esophagectomy.
Nigro JJ; DeMeester SR; Hagen JA; DeMeester TR; Peters JH; Kiyabu M; Campos GM; Oberg S; Gastal O; Crookes PF; Bremner CG
J Thorac Cardiovasc Surg; 1999 May; 117(5):960-8. PubMed ID: 10220691
[TBL] [Abstract][Full Text] [Related]
65. A multicenter study of survival after neoadjuvant radiotherapy/chemotherapy and esophagectomy for ypT0N0M0R0 esophageal cancer.
Vallböhmer D; Hölscher AH; DeMeester S; DeMeester T; Salo J; Peters J; Lerut T; Swisher SG; Schröder W; Bollschweiler E; Hofstetter W
Ann Surg; 2010 Nov; 252(5):744-9. PubMed ID: 21037429
[TBL] [Abstract][Full Text] [Related]
66. Comparison of the prognostic value of the 6th and 7th editions of the Union for International Cancer Control TNM staging system in patients with lower esophageal cancer undergoing neoadjuvant chemotherapy followed by surgery.
Mehta SP; Jose P; Mirza A; Pritchard SA; Hayden JD; Grabsch HI
Dis Esophagus; 2013; 26(2):182-8. PubMed ID: 22591020
[TBL] [Abstract][Full Text] [Related]
67. Skeletonizing en bloc esophagectomy for cancer.
Collard JM; Otte JB; Fiasse R; Laterre PF; De Kock M; Longueville J; Glineur D; Romagnoli R; Reynaert M; Kestens PJ
Ann Surg; 2001 Jul; 234(1):25-32. PubMed ID: 11420480
[TBL] [Abstract][Full Text] [Related]
68. Multifocal neoplasia and nodal metastases in T1 esophageal carcinoma: implications for endoscopic treatment.
Altorki NK; Lee PC; Liss Y; Meherally D; Korst RJ; Christos P; Mazumdar M; Port JL
Ann Surg; 2008 Mar; 247(3):434-9. PubMed ID: 18376186
[TBL] [Abstract][Full Text] [Related]
69. Esophagectomy with extended lymphadenectomy for submucosal esophageal cancer: long-term outcomes and prognostic factors.
Tanaka T; Matono S; Nagano T; Shirouzu K; Fujita H; Yamana H
Ann Surg Oncol; 2012 Mar; 19(3):750-6. PubMed ID: 21861216
[TBL] [Abstract][Full Text] [Related]
70. Salvage Esophagectomy After Definitive Chemoradiotherapy for Patients with Esophageal Squamous Cell Carcinoma: Who Really Benefits from this High-Risk Surgery?
Watanabe M; Mine S; Nishida K; Yamada K; Shigaki H; Matsumoto A; Sano T
Ann Surg Oncol; 2015 Dec; 22(13):4438-44. PubMed ID: 25862582
[TBL] [Abstract][Full Text] [Related]
71. [Prognostic analysis of clinicopathological factors in patients after radical resection of esophageal carcinoma].
Zhu SC; Song CL; Shen WB; Su JW; Li J; Liu ZK
Zhonghua Zhong Liu Za Zhi; 2012 Apr; 34(4):281-6. PubMed ID: 22781041
[TBL] [Abstract][Full Text] [Related]
72. Phase II study of preoperative paclitaxel/cisplatin with radiotherapy in locally advanced esophageal cancer.
Kim DW; Blanke CD; Wu H; Shyr Y; Berlin J; Beauchamp RD; Chakravarthy B
Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):397-404. PubMed ID: 17097833
[TBL] [Abstract][Full Text] [Related]
73. [Resection of esophageal cancer infiltrating the left main bronchus following complete response to preoperative radiochemotherapy--a case report].
Takemura M; Osugi H; Lee S; Taguchi S; Kaneko M; Tanaka Y; Fukuhara K; Fujiwara Y; Nishizawa S; Kinoshita H
Gan To Kagaku Ryoho; 2003 Nov; 30(12):1949-53. PubMed ID: 14650965
[TBL] [Abstract][Full Text] [Related]
74. Does cell type influence post-esophagectomy survival in patients with esophageal cancer?
Salazar JD; Doty JR; Lin JW; Dyke MC; Roberts J; Heitmiller ES; Heitmiller RF
Dis Esophagus; 1998 Jul; 11(3):168-71. PubMed ID: 9844798
[TBL] [Abstract][Full Text] [Related]
75. Survival after neoadjuvant therapy compared with surgery alone for resectable esophageal cancer in a population-based study.
Rouvelas I; Zeng W; Lindblad M; Viklund P; Ye W; Lagergren J
World J Surg; 2006 Dec; 30(12):2182-90; discussion 2191-2. PubMed ID: 17006610
[TBL] [Abstract][Full Text] [Related]
76. [En-bloc resection of the esophagus in esophageal cancer].
Siewert JR; Hölscher AH; Roder J; Bartels H
Langenbecks Arch Chir; 1988; 373(6):367-76. PubMed ID: 3210852
[TBL] [Abstract][Full Text] [Related]
77. Surgical treatment for carcinoma of the thoracic esophagus with major involvement in the neck or upper mediastinum.
Matsubara T; Ueda M; Nagao N; Takahashi T; Nakajima T; Nishi M
J Surg Oncol; 1998 Jan; 67(1):6-10. PubMed ID: 9457249
[TBL] [Abstract][Full Text] [Related]
78. [Surgical treatment of esophageal cancer : Evolution of management and prognosis over the last 3 decades].
Glatz T; Marjanovic G; Zirlik K; Brunner T; Hopt UT; Makowiec F; Hoeppner J
Chirurg; 2015 Jul; 86(7):662-9. PubMed ID: 25312491
[TBL] [Abstract][Full Text] [Related]
79. [Neoadjuvant therapy for resectable esophageal cancer].
Hejna M; Raderer M
Z Gastroenterol; 2005 Oct; 43(10):1141-7. PubMed ID: 16220454
[TBL] [Abstract][Full Text] [Related]
80. Early stage results after oesophageal resection for malignancy - colon interposition vs. gastric pull-up.
Kolh P; Honore P; Degauque C; Gielen J; Gerard P; Jacquet N
Eur J Cardiothorac Surg; 2000 Sep; 18(3):293-300. PubMed ID: 10973538
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
